Biotech Startups
10,023 companies tagged Biotech, with their investors and founders.
The page promotes GARUDA4D, an online gambling platform offering slot games, live casino, digital table games, cockfighting, and fish shooting games. It is a gaming/betting website targeting players in Indonesia.
0 investors
Microvascular Tissues is a commercial-stage company that develops tissue-based medical solutions. The company was established as a spin-out from Tornier, Inc., now part of Stryker Corp.
0 investors
0 investors
Microvi is a biotechnology company that develops MicroNiche Engineering (MNE) biocatalyst systems for water and wastewater treatment, including nitrogen, nitrate, phosphorus, and hexavalent chromium removal, as well as industrial bioprocessing applications. It serves municipal water utilities and industrial customers across the United States and United Kingdom.
0 investors
0 investors
A biotech company focused on infectious diseases, drawing on clinical and pharmaceutical development expertise across areas such as fungal diseases, bacterial infections, and vaccines. The company is led by physicians and scientists with backgrounds in infectious disease research, clinical development, and commercialization.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Minerva Biotechnologies develops cancer and stem cell therapeutics, including cancer immunotherapies aimed at solid tumors and preventing cancer metastasis. The company also works on patient-derived stem cells for regenerative medicine.
0 investors
MingSight Pharmaceuticals is a clinical-stage biopharmaceutical company developing MS-553, an orally administered selective protein kinase C (PKC) inhibitor. Its lead candidate targets diabetic macular edema and diabetic retinopathy in ophthalmology, as well as chronic lymphocytic leukemia and small lymphocytic lymphoma in oncology.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Mitochon is an early-stage biopharmaceutical company developing therapeutics. The page does not provide details about specific products, target indications, or customer segments beyond the biopharmaceutical sector.
0 investors
0 investors
MitoSense develops Mitochondria Organelle Transplantation (MOT) technology, a cellular biotherapy that uses mitochondria to treat neurodegenerative diseases such as ALS, Parkinson's, and Alzheimer's. The company holds an exclusive license to the MOT technology and is developing it as a cell therapy.
0 investors
0 investors